Dachaigh › Luchd-obrach › ReCode Therapeutics, Inc.
ReCode Therapeutics, Inc.: Tuarastalan H-1B agus taic bhìosa
Chuir ReCode Therapeutics, Inc. 10 iarrtasan cumha-obrach a-steach airson bhìosaichean H-1B agus bhìosaichean co-cheangailte ann am bliadhnaichean ionmhais 2023–2026; le teisteanas: 10. Tuarastal meadhanach a chaidh a thabhann: $113,629.
A bheil ReCode Therapeutics, Inc. a’ toirt taic do bhìosaichean H-1B?
Chuir ReCode Therapeutics, Inc. 10 iarrtasan cumha-obrach a-steach ann am bliadhnaichean ionmhais 2023–2026, an tè as ùire air a chur a-steach air 14 Gibl 2025. Is e LCA a’ chiad cheum ann an iarrtas H-1B, mar sin tha an neach-fastaidh air taic a thoirt do luchd-obrach H-1B no air ullachadh airson sin a dhèanamh; cha gharantaich e taic airson dreuchd shònraichte sam bith. Thoir sùil air liostaichean obrach an neach-fastaidh fhèin.
Tuarastalan a rèir tiotal obrach
| Tiotal dreuchd | LCAs | Tuarastal meadhanach |
|---|---|---|
| Scientist II | 2 | $135,000 |
| Senior Research Associate I, Gene Editing | 1 | $115,000 |
| Research Associate, Aerosol - Lipid Nano Particle | 1 | $79,560 |
| Senior Manager, IT Infrastructure and Security | 1 | $185,000 |
| Research Associate II | 1 | $90,000 |
| Senior Director, Formulations and Process Development | 1 | $148,408 |
| Research Associate II, Bioanalytical | 1 | $88,000 |
| Scientist I, In Vitro Pharmacology | 1 | $112,258 |
| Senior Research Associate I | 1 | $76,000 |
Iarrtasan a rèir bliadhna ionmhais
| Bliadhna mhaoine | LCAs | Tuarastal meadhanach |
|---|---|---|
| FY2023 | 4 | $110,000 |
| FY2024 | 3 | $115,000 |
| FY2025 | 3 | $112,258 |
Ìrean tuarastail làithreach
Suidhichidh Roinn an Obrach ceithir ìrean tuarastail làithreach airson gach dreuchd agus sgìre, bho Ìre I (inntrigeadh) gu Ìre IV (gu tur comasach). Taghaidh an neach-fastaidh an ìre a fhreagras ri riatanasan na h-obrach.
Far a bheil na h-obraichean
Dreuchdan
- Molecular and Cellular Biologists5
- Bioengineers and Biomedical Engineers2
- Biological Technicians2
- Computer and Information Systems Managers1
Iarrtasan as ùire
| Tiotal dreuchd | Tuarastal bunasach | Àite | Air a chur a-steach | Ceann-latha tòiseachaidh | Inbhe |
|---|---|---|---|---|---|
| Scientist I, In Vitro Pharmacology | $112,258–$130,000 Ìre II | Menlo Park, CA | 14 Gibl 2025 | 1 Dàmh 2025 | Dearbhaichte |
| Senior Director, Formulations and Process Development | $148,408–$275,000 Ìre IV | Menlo Park, CA | 4 Ògmh 2024 | 1 Dàmh 2024 | Dearbhaichte |
| Research Associate II, Bioanalytical | $88,000 Ìre IV | Menlo Park, CA | 3 Cèit 2024 | 1 Dàmh 2024 | Dearbhaichte |
| Scientist II | $130,000 Ìre III | Menlo Park, CA | 4 Lùna 2023 | 1 Dàmh 2023 | Dearbhaichte |
| Research Associate II | $90,000 Ìre IV | Menlo Park, CA | 11 Iuch 2023 | 31 Iuch 2023 | Dearbhaichte |
| Research Associate, Aerosol - Lipid Nano Particle | $79,560 Ìre I | Menlo Park, CA | 3 Cèit 2023 | 1 Dàmh 2023 | Dearbhaichte |
| Senior Manager, IT Infrastructure and Security | $185,000 Ìre II | Menlo Park, CA | 21 Gibl 2023 | 15 Cèit 2023 | Dearbhaichte |
| Scientist II | $140,000 Ìre IV | Menlo Park, CA | 17 Gibl 2023 | 1 Cèit 2023 | Dearbhaichte, an uair sin air a tharraing air ais |
| Senior Research Associate I, Gene Editing | $115,000 Ìre III | Menlo Park, CA | 1 Màrt 2023 | 13 Màrt 2023 | Dearbhaichte, an uair sin air a tharraing air ais |
| Senior Research Associate I | $76,000 Ìre II | Dallas, TX | 24 Cèit 2022 | 1 Dàmh 2022 | Dearbhaichte, an uair sin air a tharraing air ais |
Is e na tuarastalan an ìre as ìsle den tuarastal a chaidh a thabhann air gach iarrtas, air an tionndadh gu suim bhliadhnail; cleachdaidh na staitistigean iarrtasan làn-aimsire le teisteanas a-mhàin. Chan eil LCA na aontachadh bhìosa agus faodaidh aon LCA còmhdach a dhèanamh air iomadh dreuchd. Stòr: Roinn an Obrach na SA, Dàta Foillseachaidh OFLC LCA, bliadhnaichean ionmhais 2023–2026 (co-dhùnadh as ùire 30 Ògmh 2026).